Section Arrow
ATRC.NASDAQ
- AtriCure
Quotes are at least 15-min delayed:2025/09/17 10:06 EDT
Regular Hours
Last
 35.73
-0.23 (-0.64%)
Day High 
36.04 
Prev. Close
35.96 
1-M High
38.33 
Volume 
15.26K 
Bid
35.65
Ask
35.79
Day Low
35.66 
Open
36.01 
1-M Low
34.21 
Market Cap 
1.79B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 35.63 
20-SMA 36.26 
50-SMA 34.39 
52-W High 43.11 
52-W Low 25.57 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.77/-0.25
Enterprise Value
1.86B
Balance Sheet
Book Value Per Share
9.35
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
465.31M
Operating Revenue Per Share
7.66
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MBOTMicrobot Medical3.18-0.16-4.79%-- 
BNGOBionano Genomics Inc1.7899+0.0099+0.56%0.02PE
AVTRAvantor12.765+0.055+0.43%12.58PE
BAXBaxter International23.765-0.105-0.44%140.32PE
HBIOHarvard Bioscience0.4662-0.0187-3.86%-- 
Quotes are at least 15-min delayed:2025/09/17 10:06 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct salesforce and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.